Yeqiong Zhang
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
RGMA gene polymorphisms as predictive biomarkers for early relapse in neuromyelitis optica spectrum disorders.
Journal: Neurobiology of disease
Published: February 12, 2025
Predict disabling severe attacks in neuromyelitis optica spectrum disorders: warning symptoms and innovative machine learning models.
Journal: Journal of translational medicine
Published: January 27, 2025
Decreased NETosis-related regulators in neuromyelitis optica spectrum disorders after plasma exchange.
Journal: International immunopharmacology
Published: February 29, 2024
FCGR3A-V158F gene polymorphism: A potential predictor for rituximab dosing optimization in Chinese patients with neuromyelitis optica spectrum disorder.
Journal: Multiple sclerosis and related disorders
Published: November 18, 2023
Therapeutic efficacy and safety of plasmapheresis in elderly patients with neuromyelitis optica spectrum disorder: a single-center observational study.
Journal: Therapeutic advances in neurological disorders
Published: October 13, 2022
COVID-19-associated meningoencephalitis: A care report and literature review.
Journal: Experimental and therapeutic medicine
Published: September 01, 2020
Questioning the existence of monophasic neuromyelitis optica spectrum disorder by defining a novel long-term relapse-free form from a large Chinese population.
Journal: Journal of neurology
Published: October 17, 2019
Early identification of anti-NMDA receptor encephalitis presenting cerebral lesions in unconventional locations on magnetic resonance imaging.
Journal: Journal of neuroimmunology
Published: November 25, 2017
Plasma Exchange for Neuromyelitis Optica Spectrum Disorders in Chinese Patients and Factors Predictive of Short-term Outcome.
Journal: Clinical therapeutics
Published: October 05, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026